FDA Expands Approval of Osimertinib in Lung Cancer

Published Date: 30 Sep 2024

EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pickleball program boosts health and wellness for cancer survivors, study finds

2.

A video animation guide to assist young people who are fatigued from cancer.

3.

Is Exercise an Effective Treatment for Prostate Cancer?

4.

High resolution ultrasound could enable faster prostate cancer diagnosis

5.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot